CY1115310T1 - Χρηση ολιγομερων γαλακτικου οξεος στη αντιμετωπιση γυναικολογικων λοιμωξεων - Google Patents
Χρηση ολιγομερων γαλακτικου οξεος στη αντιμετωπιση γυναικολογικων λοιμωξεωνInfo
- Publication number
- CY1115310T1 CY1115310T1 CY20141100463T CY141100463T CY1115310T1 CY 1115310 T1 CY1115310 T1 CY 1115310T1 CY 20141100463 T CY20141100463 T CY 20141100463T CY 141100463 T CY141100463 T CY 141100463T CY 1115310 T1 CY1115310 T1 CY 1115310T1
- Authority
- CY
- Cyprus
- Prior art keywords
- lactic acid
- infection
- treatment
- vaginitis
- bacterial
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 6
- 235000014655 lactic acid Nutrition 0.000 title abstract 3
- 239000004310 lactic acid Substances 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 abstract 2
- 241000222122 Candida albicans Species 0.000 abstract 2
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 241000701806 Human papillomavirus Species 0.000 abstract 2
- 241000700584 Simplexvirus Species 0.000 abstract 2
- 208000004746 Atrophic Vaginitis Diseases 0.000 abstract 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010007134 Candida infections Diseases 0.000 abstract 1
- 201000007336 Cryptococcosis Diseases 0.000 abstract 1
- 241000221204 Cryptococcus neoformans Species 0.000 abstract 1
- 206010017533 Fungal infection Diseases 0.000 abstract 1
- 206010061977 Genital infection female Diseases 0.000 abstract 1
- 208000031888 Mycoses Diseases 0.000 abstract 1
- 208000006374 Uterine Cervicitis Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 201000007691 actinomycosis Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 229940095731 candida albicans Drugs 0.000 abstract 1
- 201000003984 candidiasis Diseases 0.000 abstract 1
- 206010008323 cervicitis Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 abstract 1
- 210000003708 urethra Anatomy 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200700508 | 2007-03-30 | ||
| EP08734874.4A EP2142186B1 (en) | 2007-03-30 | 2008-03-28 | Use of oligomers of lactic acid in the treatment of gynaecological infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115310T1 true CY1115310T1 (el) | 2017-01-04 |
Family
ID=39494560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100463T CY1115310T1 (el) | 2007-03-30 | 2014-06-26 | Χρηση ολιγομερων γαλακτικου οξεος στη αντιμετωπιση γυναικολογικων λοιμωξεων |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US8425894B2 (enExample) |
| EP (2) | EP2679222A1 (enExample) |
| JP (2) | JP5409596B2 (enExample) |
| KR (1) | KR101518014B1 (enExample) |
| CN (2) | CN101677980B (enExample) |
| AU (1) | AU2008234064B2 (enExample) |
| BR (1) | BRPI0809330B8 (enExample) |
| CA (1) | CA2681803C (enExample) |
| CY (1) | CY1115310T1 (enExample) |
| DK (1) | DK2142186T3 (enExample) |
| ES (1) | ES2482190T3 (enExample) |
| HR (1) | HRP20140559T1 (enExample) |
| MX (1) | MX2009010445A (enExample) |
| PL (1) | PL2142186T3 (enExample) |
| PT (1) | PT2142186E (enExample) |
| RU (1) | RU2459620C2 (enExample) |
| SI (1) | SI2142186T1 (enExample) |
| WO (1) | WO2008119518A1 (enExample) |
| ZA (1) | ZA200907215B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0809330B8 (pt) | 2007-03-30 | 2021-05-25 | Laccure Ab | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica |
| CN101797269B (zh) * | 2010-03-23 | 2012-01-04 | 杨霞 | 一种调节女性阴道微生态的生理平衡液 |
| RU2422147C1 (ru) * | 2010-03-29 | 2011-06-27 | Государственное образовательное учреждение высшего профессионального образования "Пермская государственная медицинская академия имени академика Е.А. Вагнера Федерального агентства по здравоохранению и социальному развитию" | Способ лечения неспецифического аэробного вагинита |
| WO2012158779A1 (en) | 2011-05-17 | 2012-11-22 | Reprotect, Inc. | Reusable intravaginal delivery device, system, and method |
| CN102274333A (zh) * | 2011-08-22 | 2011-12-14 | 谢英华 | 一种治疗阴道炎的外洗中药 |
| CN102579829B (zh) * | 2012-03-06 | 2013-09-18 | 康莉 | 一种治疗牛放线菌病的中药组合物及其制备方法 |
| JP6352907B2 (ja) | 2012-06-13 | 2018-07-04 | イボフェム， インコーポレイテッド | 避妊殺菌剤の効果を増強するための組成物および方法 |
| JP6149109B2 (ja) * | 2012-07-16 | 2017-06-14 | ラキュアー エービーＬａｃｃｕｒｅ Ａｂ | 乳酸オリゴマー含有医薬組成物 |
| CN102885850B (zh) * | 2012-10-15 | 2013-08-07 | 山东省医疗器械研究所 | 一种治疗阴道炎的多孔凝胶颗粒剂 |
| RU2691950C1 (ru) | 2013-12-19 | 2019-06-19 | Ивофем, Инк. | Композиции и способы ингибирования воспаления и заболеваний с применением антимикробного соединения на основе альгиновой кислоты |
| US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
| MX382396B (es) | 2016-04-06 | 2025-03-13 | Gedea Biotech Ab | Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales. |
| US10249017B2 (en) * | 2016-08-11 | 2019-04-02 | Intel Corporation | Apparatus and method for shared resource partitioning through credit management |
| US20190209502A1 (en) * | 2016-09-12 | 2019-07-11 | Evofem, Inc. | Combination gel for sexually transmitted infections |
| EP3522879A4 (en) | 2016-10-04 | 2020-06-03 | Evofem, Inc. | Method of treatment and prevention of bacterial vaginosis |
| CA3040422A1 (en) * | 2016-10-13 | 2018-04-19 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
| PL3773501T3 (pl) * | 2018-03-29 | 2024-03-11 | The Materia Company Limited | Preparat dopochwowy |
| CN113423470B (zh) * | 2019-02-13 | 2024-07-09 | 三吉油脂株式会社 | 化妆品配合剂、化妆品及其制造方法 |
| EP4240321A1 (en) * | 2020-11-09 | 2023-09-13 | Peptonic Medical AB | Composition for treating and/or preventing fungal infections |
| US20250161348A1 (en) | 2022-03-01 | 2025-05-22 | Combe Incorporated | Process for preparation of compositions of oligomers of lactic acid |
| EP4590289A4 (en) * | 2023-07-07 | 2025-11-26 | Changchun Sinobiomaterials Co Ltd | MUSCLE ATROPHY |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431427A (en) * | 1981-10-05 | 1984-02-14 | University Of Delaware | Tampons and their manufacture |
| US5274127A (en) * | 1990-09-18 | 1993-12-28 | Biopak Technology, Ltd. | Lactide production from dehydration of aqueous lactic acid feed |
| JP2919912B2 (ja) | 1990-05-23 | 1999-07-19 | 鐘紡株式会社 | 修飾プロテアーゼ及びその製造法 |
| US5142023A (en) * | 1992-01-24 | 1992-08-25 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| JPH07132127A (ja) | 1993-06-17 | 1995-05-23 | Mitsui Toatsu Chem Inc | 生理用ナプキン |
| JPH07258526A (ja) | 1994-02-24 | 1995-10-09 | Ecological Chem Prod Co | 水分含有食品を包装するための組成物及び方法 |
| US5521278A (en) * | 1994-08-18 | 1996-05-28 | Ecological Chemical Products | Integrated process for the manufacture of lactide |
| JP2864218B2 (ja) | 1994-12-06 | 1999-03-03 | 株式会社日本製鋼所 | ポリ乳酸共重合体の製造方法 |
| US6369116B1 (en) * | 1995-06-02 | 2002-04-09 | Oculex Pharmaceuticals, Inc. | Composition and method for treating glaucoma |
| JPH09227388A (ja) * | 1996-02-15 | 1997-09-02 | Naganushi Tetsuaki | 大腸癌、食道癌及び乳癌より選ばれた癌に用いる抗悪性腫瘍剤 |
| WO1997045066A1 (en) | 1996-05-31 | 1997-12-04 | Uromed Corporation | Urinary medical devices |
| US6229046B1 (en) | 1997-10-14 | 2001-05-08 | Cargill, Incorported | Lactic acid processing methods arrangements and products |
| JP2000072680A (ja) * | 1998-08-25 | 2000-03-07 | Shiyumeidou:Kk | 免疫機能調節剤 |
| JP2001139476A (ja) * | 1999-11-15 | 2001-05-22 | Youichirou Naganushi | 癌を含めた悪性新生物に用いる抗悪性腫瘍剤 |
| RU2163810C1 (ru) * | 2000-05-18 | 2001-03-10 | Майорова Нина Федоровна | Состав для удаления доброкачественных новообразований на коже и слизистых и способ его получения |
| EP1358884A1 (en) | 2001-01-12 | 2003-11-05 | Amato Pharmaceutical Products, Ltd. | Preventives for microbial infections |
| EP1362594A1 (en) | 2001-01-24 | 2003-11-19 | Amato Pharmaceutical Products, Ltd. | Anti-stress agents |
| US20020177624A1 (en) * | 2001-03-16 | 2002-11-28 | Calvin Hanna | Acetate-lactate buffering vaginal gel and for method of making same and treating bacterial vaginosis |
| JP2002275256A (ja) * | 2001-03-19 | 2002-09-25 | Tendou Seiyaku Kk | 乳酸オリゴマーの製造方法 |
| AU2002325614A1 (en) * | 2001-08-16 | 2003-03-03 | Pharmacon-Forschung Und Beratung Gmbh | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
| TW200300080A (en) | 2001-11-06 | 2003-05-16 | Education Instr Co Ltd | Antitumor agent containing lactic acid oligomer mixture |
| JP2004307561A (ja) | 2003-04-02 | 2004-11-04 | Tendou Seiyaku Kk | 環状乳酸オリゴマーの製造方法 |
| SI1617834T1 (sl) | 2003-05-01 | 2007-02-28 | Innogene Kalbiotech Pte Ltd | Uporaba farmacevtskega sestavka, ki vsebuje mlecno kislino ali laktat in kalij, za zdravljenje mozganskega edema in mozganske poskodbe |
| JP4316299B2 (ja) | 2003-06-03 | 2009-08-19 | 学校法人東海大学 | 鎖状乳酸オリゴマー誘導体およびその製造方法 |
| JP2005126361A (ja) * | 2003-10-23 | 2005-05-19 | Tendou Seiyaku Kk | ポリ乳酸混合物を含むマトリックスメタロプロテアーゼ抑制剤 |
| CN1562049A (zh) * | 2004-04-02 | 2005-01-12 | 聂四平 | 低聚果糖在制备治疗及预防阴道炎药中的应用 |
| US20050271726A1 (en) * | 2004-06-02 | 2005-12-08 | Albert Crum | Immune enhancing compositions and methods of use thereof |
| SE528337C2 (sv) * | 2004-06-23 | 2006-10-24 | Nestor Medical Ab | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
| JP2006232909A (ja) | 2005-02-23 | 2006-09-07 | Tokai Univ | 環状オリゴ乳酸 |
| JP4431102B2 (ja) | 2005-11-11 | 2010-03-10 | キャタピラージャパン株式会社 | カウンタウエイト及びカウンタウエイトの製造方法並びに作業機械 |
| RU2308970C1 (ru) * | 2006-03-10 | 2007-10-27 | Автономная некоммерческая организация "Институт молекулярной диагностики" (АНО "ИнМоДи") | Антибактериальное средство для лечения внутриклеточных инфекций |
| JP2007258526A (ja) | 2006-03-24 | 2007-10-04 | Konica Minolta Holdings Inc | 有機エレクトロルミネッセンス素子、及び有機エレクトロルミネッセンスディスプレイ |
| JP2008157576A (ja) | 2006-12-26 | 2008-07-10 | Sharp Corp | 加湿機 |
| BRPI0809330B8 (pt) | 2007-03-30 | 2021-05-25 | Laccure Ab | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica |
-
2008
- 2008-03-28 BR BRPI0809330A patent/BRPI0809330B8/pt active IP Right Grant
- 2008-03-28 AU AU2008234064A patent/AU2008234064B2/en active Active
- 2008-03-28 RU RU2009140141/15A patent/RU2459620C2/ru active
- 2008-03-28 PL PL08734874T patent/PL2142186T3/pl unknown
- 2008-03-28 JP JP2010500144A patent/JP5409596B2/ja not_active Expired - Fee Related
- 2008-03-28 DK DK08734874.4T patent/DK2142186T3/da active
- 2008-03-28 SI SI200831231T patent/SI2142186T1/sl unknown
- 2008-03-28 US US12/594,147 patent/US8425894B2/en active Active
- 2008-03-28 EP EP13183687.6A patent/EP2679222A1/en not_active Withdrawn
- 2008-03-28 CN CN2008800161538A patent/CN101677980B/zh active Active
- 2008-03-28 WO PCT/EP2008/002505 patent/WO2008119518A1/en not_active Ceased
- 2008-03-28 MX MX2009010445A patent/MX2009010445A/es active IP Right Grant
- 2008-03-28 HR HRP20140559AT patent/HRP20140559T1/hr unknown
- 2008-03-28 KR KR1020097022696A patent/KR101518014B1/ko not_active Expired - Fee Related
- 2008-03-28 EP EP08734874.4A patent/EP2142186B1/en active Active
- 2008-03-28 ES ES08734874.4T patent/ES2482190T3/es active Active
- 2008-03-28 CN CN201310450505.3A patent/CN103830216B/zh active Active
- 2008-03-28 CA CA2681803A patent/CA2681803C/en active Active
- 2008-03-28 PT PT87348744T patent/PT2142186E/pt unknown
-
2009
- 2009-10-15 ZA ZA2009/07215A patent/ZA200907215B/en unknown
-
2013
- 2013-03-28 US US13/852,668 patent/US8912232B2/en active Active
- 2013-08-01 JP JP2013160602A patent/JP5793542B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-20 US US14/311,200 patent/US9315444B2/en active Active
- 2014-06-26 CY CY20141100463T patent/CY1115310T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0809330B8 (pt) | uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica | |
| CY1119269T1 (el) | Θεραπεια βλαβων που προκαλουνται απο ιους | |
| WO2009129470A3 (en) | Methods for treating herpes virus infections | |
| EP1992645A4 (en) | NEW LOW-MOLECULAR HYALURONIC ACID AND / OR SALT AND COSMETIC PREPARATION, PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION THEREWITH | |
| CY1113684T1 (el) | Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη | |
| FI4108671T3 (fi) | Muokattuja nukleosideja, nukleotideja ja nukleiinihappoja sekä niiden käyttötapoja | |
| CY1115585T1 (el) | Κρυσταλλικες μορφες του αλατος του νατριου της 5-αμινο-2,3-διυδροφθαλαζιν-1,4-διονης, οι οποιες περιεχουν φαρμακευτικα σκευασματα και διαδικασιες για την παρασκευη τους | |
| CY1113949T1 (el) | Αντιιικη συνθεση, η οποια περιεχει εναν θειικο πολυσακχαριτη: ι-καρραγενανη | |
| MX372534B (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
| WO2010084115A3 (en) | Antiviral agents | |
| WO2007121894A3 (en) | Hpv-18-based papillomavirus vaccine | |
| CL2008003819A1 (es) | Compuestos derivados del acido 2-cetoamino benzoico sustituido, inhibidores del virus de la hepatitis c; composicion farmaceutica; y su uso en el tratamiento de una infeccion por vhc. | |
| CY1110665T1 (el) | Αναστολεις hiv ιντεγκρασης | |
| MX2014009546A (es) | Compuestos antivirales con una porcion heterotriciclica. | |
| BRPI0707302B8 (pt) | compostos de cianoisoquinolina que atuam no dano tecidual associado com isquemia, hipóxia e anemia, bem como composição farmacêutica que os compreende | |
| WO2008095040A3 (en) | 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents | |
| MX385354B (es) | Sales de xantilio 3,6-disustituidas. | |
| BRPI1012666B8 (pt) | cocristal de etravirina e nicotinamida, composição farmacêutica, combinação compreendendo o mesmo, seu processo para a preparação e uso | |
| PT2301572E (pt) | Vacinas virais derivadas de células com níveis baixos de adn celular residual | |
| IL203873A0 (en) | Novel targets and compounds for therapeutic intervention of hiv infection | |
| BRPI0606123A2 (pt) | pirrolidinas fenil-substituìdas | |
| EA201490963A1 (ru) | Новые производные гемина с антибактериальной и противовирусной активностью | |
| EP2182937A4 (en) | ANTIVIRAL COMPOSITION | |
| AR056137A1 (es) | Un conjugado peptido inmunoglobulina y su uso como antiviral | |
| MY159790A (en) | Highly bridged peptides from actinomadura namibiensis |